List of insiders holdings for Zentalis Pharmaceuticals Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Matrix Capital Management Company LP GOEL DAVID E. 10% Owner | 2025-12-15 17:24:17 | 0 6,459,973 | 6,459,973 | Form 4 |
| 2 | Recurium Equity LLC 10% Owner | 2020-10-30 19:53:12 | 4,162,930 0 | 4,162,930 | Form 4 |
| 3 | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner | 2022-02-14 17:01:24 | 2,118,284 0 | 2,118,284 | Form 13G |
| 4 | Paul Andrea Chief Legal Officer | 2025-02-05 18:31:59 | 1,195,498 0 | 1,195,498 | Form 4 |
| 5 | Bunker Kevin D. Chief Scientific Officer | 2023-12-21 17:47:53 | 834,931 15,350 | 850,281 | Form 4 |
| 6 | Blackwell Kimberly Chief Executive Officer | 2024-02-05 19:11:29 | 734,145 0 | 734,145 | Form 4 |
| 7 | Lackner Mark Chief Scientific Officer | 2025-02-05 18:32:31 | 637,570 0 | 637,570 | Form 4 |
| 8 | Gallagher Cam President, Interim CFO | 2024-05-31 18:27:15 | 633,680 0 | 633,680 | Form 4 |
| 9 | Epperly Melissa B Chief Financial Officer | 2024-02-12 20:22:44 | 451,449 0 | 451,449 | Form 4 |
| 10 | Bucher James B Chief Legal Officer | 2025-10-01 18:40:25 | 400,000 0 | 400,000 | Form 4 |
| 11 | HAUSMAN DIANA Chief Medical Officer | 2024-05-09 19:46:59 | 373,876 0 | 373,876 | Form 4 |
| 12 | SUN ANTHONY Y President & CEO | 2023-03-09 19:16:00 | 360,542 0 | 360,542 | Form 13G |
| 13 | Roth Iris Chief Operating Officer | 2023-03-02 16:30:11 | 350,000 0 | 350,000 | Form 4 |
| 14 | Myers Scott Dunseth Director | 2025-06-18 16:12:25 | 338,795 0 | 338,795 | Form 4 |
| 15 | Johnson David Michael Director | 2025-06-18 16:15:49 | 250,421 0 | 250,421 | Form 4 |
| 16 | Vultaggio Vincent PAO and Interim PFO | 2025-02-05 18:33:02 | 225,459 0 | 225,459 | Form 4 |
| 17 | Skvarka Jan Director | 2025-06-18 16:17:03 | 207,154 0 | 207,154 | Form 4 |
| 18 | EASTLAND JULIA MARIE CEO & President | 2025-02-05 18:29:57 | 147,276 0 | 147,276 | Form 4 |
| 19 | Walker Luke Nathaniel Director | 2025-06-18 16:19:09 | 144,284 0 | 144,284 | Form 4 |
| 20 | Kariuki Enoch Director | 2025-06-18 16:14:02 | 137,365 0 | 137,365 | Form 4 |
| 21 | Brownstein Carrie Chief Medical Officer | 2023-10-06 19:19:49 | 105,685 0 | 105,685 | Form 4 |
| 22 | Pinto Alexis Chief Legal Officer | 2022-02-14 21:10:22 | 60,729 0 | 60,729 | Form 4 |
| 23 | Voliotis Dimitris SVP, Clinical Development | 2022-02-14 21:10:45 | 40,212 0 | 40,212 | Form 4 |
| 24 | Bruns Ingmar Chief Medical Officer | 2025-02-12 17:00:31 | 36,629 0 | 36,629 | Form 4 |
| 25 | Takhar Karan S. Director | 2020-04-03 17:59:21 | 0 0 | 0 | Form 3 |